Difficult to read
12/02/20 -"Akzo’s FY figures leave certain room for interpretation as we really need to see the annual report. EBITDA is the central metric for our valuation and this line could be seen at various levels. ..."
Pages
63
Language
English
Published on
12/02/20
You may also be interested by these reports :
27/02/26
BASF’s Q4 2025 sales declined due to pricing pressure despite positive volumes, with Chemicals being most affected by oversupply. Materials saw ...
27/02/26
Arkema’s Q4 2025 earnings lagged behind market estimates amid continued de-stocking and weakness in the U.S. and Europe, with Asia being the only ...
26/02/26
Clariant’s Q4 2025 sales growth was volume-led, with pricing broadly flat. Higher volumes and performance improvement initiatives drove a meaningful ...
26/02/26
Arkema’s Q4 2025 results were broadly weak despite a modest sales beat. Sales declined across segments but exceeded expectations across divisions ...